Expiration of Gleevac patent could save patients millions of dollars
Tuesday, March 15, 2016 - 12:30
in Health & Medicine
Stephen FellerBALTIMORE, March 15 (UPI) -- Switching to a generic form of the cancer drug Gleevac could save patients $100,000 over 5 years, translating to huge savings for insurance companies.